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Distinguishing specific cells is an essential technique in cell research and clinical diagnostics. We report
a novel method to passively isolate and extract cells in a microfluidic device. We utilise a droplet-based
microfluidic system to generate an aqueous two phase system in which aqueous droplets consist of two
phases in the form of a double emulsion. Specifically, we generate PEG droplets that completely
encapsulate DEX droplets within a microfluidic channel. Target cells can be introduced directly into the
droplets and driven to partition to the more favourable phase, whilst still being contained within the
aqueous droplet. Human T lymphoma cells, with diameters in the range of 10–15 mm, are chosen as
a model cell line to demonstrate the partitioning.
Introduction
Over the past two decades microfluidic systems have been shown
to be extremely useful in processing small sample volumes and
have been intensively developed into valuable instrumental
platforms for chemical and biological analysis. More recently,
much attention has focused on using droplet-based or
segmented-flow microfluidic systems in high-throughput experi-
mentation.1 Such systems leverage instabilities between two or
more immiscible flows to form suspended droplets encapsulated
within a continuous carrier fluid.2 Since the droplets (or plugs)
can be controllably formed with changeable reagent composition
and at high frequencies (in excess of 1 kHz) segmented flow
systems of this kind have been used to good effect in areas such as
cell-based analysis, nanomaterial synthesis and rapid chemical
reactions.3,4 The need for cell separation in distinguishing and
isolating cells of a given type has been identified as an essential
technique in cell and tissue engineering for clinical applications in
emergent areas, such as cell therapy and regenerative medicine.5
Previously, a number of publications have reported the use of
droplet-based microfluidic systems to isolate, encapsulate and
characterise single (or small populations of) cells in high-
throughput.6,7 In these studies fluorescence-based detection
methods are commonly used to locate, identify and discriminate
cells within a specific droplet. Cell separation and sorting have
also been demonstrated in droplet-based microfluidic formats.8–11
However, in a similar manner to fluorescence activated cell
sorting, measurements typically involve the use of fluorescence
labels or tags to identify the target cells and electric fields to
navigate droplets containing target cells to a separate channel or
reservoir, while droplets containing unwanted material pass
unhindered into a waste channel.12–15 An alternative approach
involves performing liquid–liquid extraction within an aqueous
two-phase system (ATPS). Briefly, an ATPS is comprised of two
immiscible polymer phases, such as polyethylene glycol (PEG)
and dextran (DEX), or one polymer and a complementary salt
solution. Importantly, both phases in an ATPS are primarily
water-based and provide biologically friendly environments.16,17
Numerous ATPS systems have been characterised for both fluid
properties and their ability to separate different biological
materials. These include both soluble substances, such as
proteins18,19 and nucleic acids,20–23 and suspended particles, such
as whole cells.24,25 Target species, when added to an ATPS,
distribute between phases by their own thermal motion to reach
equilibrium.16 Not surprisingly, in bulk systems, particle diffu-
sion and phase separation is very slow, leading to unacceptably
long equilibrium times (on the order of many hours). Addition-
ally, the process of phase separation is extremely sensitive to
modest changes in analyte concentration. These difficulties have
been addressed in part through the transferral of ATPS to
a microfluidic format. For example, Nam et al. reported the use
of stable aqueous two-phase laminar flows in microchannels to
establish an ATPS. In this study live Chinese hamster ovary cells
introduced into the system were favourably partitioned to the
PEG phase, whilst dead cells remained at the interface between
the two phases.26 More recently, using a similar continuous-flow
microfluidic setup, Meagher et al. demonstrated protein purifi-
cation by using genetically-engineered partition tags to drive the
partitioning into the PEG phase.27 Whilst ATPS in laminar
microfluidic formats allows extraction of target species in an
efficient manner, there are difficulties associated with such
formats. For example, target particles are necessarily diluted
within the laminar flow streams used, and the adoption of
a co-flow format requires the maintenance of stable fluidic
interfaces over uncharacteristically long distances. Contrast-
ingly, a PEG/DEX combination has also been used to perform
nanolitre liquid patterning on a cell monolayer.28 A cell culture
was covered with the PEG phase and DEX droplets containing
various sets of reagents were placed on the surface to treat
discrete groups of cells.
Herein, we introduce a novel method to passively isolate,
extract and sort cells in a microfluidic device. Specifically, we
utilise a droplet-based microfluidic system to generate an ATPS
in which aqueous droplets consist of two phases in the form of
a double emulsion, with a PEG droplet completely encapsulating
a DEX droplet. Target cells can be introduced directly into the
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droplets and driven to partition to the more favourable phase,
whilst still being contained within the aqueous droplet. Human
T lymphoma (Jurkat) cells, with diameters in the range of
10–15 mm, are chosen as a model cell line to demonstrate the
partitioning. Indeed, Kumar et al. have previously shown that in
a bulk PEG–DEX ATPS, Jurkat cells efficiently partition to the
PEG phase when bound to an antibody-N-isopropylacrylamide
(Ab-NIPAM) conjugate.29 Accordingly, we too use Jurkat cells
bound to an Ab-NIPAM conjugate to demonstrate the efficacy
of our approach and show that cell migration occurs passively
and rapidly within a pL volume.
Experimental
Device fabrication and operation
The microfluidic devices used for all the experiments were
structured in polydimethylsiloxane (PDMS), using standard soft
lithography techniques. Briefly, the microchannel layout was
designed using AutoCAD (Autodesk, Inc.), printed onto an
acetate film mask (Circuit Graphics, Essex, UK) and then
transferred to an SU8 master, which serves as the mould for
subsequent soft lithography.30 PDMS base and curing agent
(Sylgard184, Dow Corning, Coventry UK) were mixed at a ratio
of 10 : 1 (w/w) and poured onto the master. After curing at 70 C,
the structured PDMS substrate was peeled off the master. Access
to the channels was achieved by punching holes at the appro-
priate reservoir locations using a biopsy punch (Kai Europe
GmBH, Solingen, Germany). The channels were then sealed by
plasma bonding a microscope cover slip to the PDMS substrate.
All devices have 2 aqueous inlets, one oil inlet and an outlet with
a uniform channel depth of 100 mm. The channel width was
100 mm, with the exception of a winding channel section of
a narrower width of 40 mm. This was introduced into the channel
network to induce chaotic mixing within the droplets.1,31,32 A
schematic and a photographic image of the device are shown in
Fig. 1a and 1d, respectively.
Droplet formation and detection
All solutions were delivered into the microfluidic channels using
1 ml BD Plastipak syringes (VWR, UK) and precision syringe
pumps (PHD 2000, Harvard Apparatus, Kent UK). The carrier
fluid was a mixture of FC 3283 oil (3M, Bracknell, UK), EGC-
1700 (3M, Bracknell, UK) and 1H,1H,2H,2H-perfluorooctanol
(Sigma-Aldrich, Dorset, UK) at a ratio of 8 : 1 : 1 (v/v/v).
Portex fine bore tubing (0.38 mm ID, 1.09 OD, Smiths Medical
International Ltd, Kent, UK) was connected to the syringes via
needles (BD Microlance 3 Nr.18, VWR, UK) and directly
inserted into the access holes in the devices. Droplets were
observed under 20 magnification and recorded using a high
speed camera (Phantom, v649).
ATPS
PEG (MW 6000) and DEX (MW 500000) were purchased from
Sigma Aldrich and used as received. ATPS were formed by dis-
solving 3.8% PEG and 5.5% DEX in 90.7% phosphate-buffered
saline (PBS, Invitrogen) (w/w/v). The ATPS solution was mixed
thoroughly using a vortex and then centrifuged at 5000g for
20 min to separate the two phases. Top and bottom phases were
extracted separately and loaded into two syringes.
Cells
Jurkat cells were obtained from American Type Culture
Collection (ATCC). The culture medium was prepared using
88% RPMI supplemented with 10% foetal bovine serum (FBS),
1% L-glutamine and 1% penicillin–streptomycin (all purchased
from Invitrogen). Jurkat cells were cultured in-house, harvested
when confluent and re-seeded to continue cell culturing. Exper-
iments were carried out using cells from cultures between
passages 0 and 10.
Cell sample preparation
Mouse monoclonal anti-CD3-FITC conjugates (Ab), itaconic
anhydride, NIPAM, ammonium persulfate (APS), N,N,N0,N0-
tetramethylethylenediamine (TEMED) and dialysis bags were
purchased from Sigma Aldrich. The protocol for the
copolymerisation of antibodies with NIPAM follows the recipe
presented by Kumar et al., with adjustments made to suit the
microfluidic environment.29 All solutions were prepared using
150 mM phosphate buffer at pH 7.8. The buffer was purchased at
pH 7 from Sigma Aldrich and 10 drops of 1 M NaOH were
added to 20 ml of buffer to increase the pH to 7.8. 100 ml of
Ab-FITC solution was added to 4.9 ml of the phosphate buffer.
While continuously stirring, 114.3 ml of itaconic anhydride was
added to this, resulting in a decrease in pH. Accordingly,
500 mM NaOH was added drop-wise to re-adjust the pH to 7.8.
Subsequently, 250 mg of glucose was added and the mixture
incubated at approximately 4 C for 30 min with continuous
stirring. Glucose was used since it is known to stabilise the
reaction with itaconic anhydride.29 The mixture was then
dialysed overnight against DI water at 4 C, with the volume of
the solution nearly doubling at the end of the dialysis. For
copolymerisation with NIPAM, 0.05 g of NIPAM was added
and the solution placed in a desiccator for de-gassing. Subse-
quently, 100 ml of APS was added and de-gassing repeated.
Finally, 10 ml of TEMED was added to the mixture. The reaction
mixture was kept on ice for 5 min and then allowed to polymerise
by incubating at 4 C for 6 h. To precipitate the Ab-NIPAM
conjugates, NaCl was added to a final concentration of 0.5 M
and the mixture heated to 30 C. Centrifugation at 9000g for 5
min allowed the precipitated conjugates to be collected in pellets
at the bottom of the centrifuge tube. The supernatant was
decanted and the pellets were dissolved in 2 ml DI water. The
Ab-NIPAM conjugates were dialysed overnight against DI water
at room temperature. The mixture was then loaded into
Eppendorf tubes in 200 ml aliquots and stored at 4 C.
To prepare the Jurkat-Ab-NIPAM conjugates, the
Ab-NIPAM aliquots were firstly diluted with DI water (1 : 4 v/v).
The Jurkat cells were incubated in the Ab-NIPAM solution for
20 min at 4 C. To ensure a stable ATPS interface on-chip, it was
essential to avoid a dilution of the DEX phase when adding the
cell suspension. Common centrifugal tubes collect the required
samples in a pellet at the bottom of the tubes, such that the
supernatant can be removed through pipetting or other aspira-
tion methods. However, this process resulted in the NIPAM


































forming large clusters rendering the conjugates unusable. Thus,
centrifugal filter units (Vivaspin 500, Fisher Scientific Ltd, UK)
were used instead. These filter units removed the supernatant
through the filters at the bottom of the tubes, leaving a Jurkat-
Ab-NIPAM suspension at high concentration. The cell suspen-
sion was centrifuged in these filter units at 1000 rpm for 10 min.
Finally, DEX was added to the high concentration cell suspen-
sion and the sample was loaded into a syringe.
Results
ATPS formation
As described above, a device to successfully introduce samples
and generate an ATPS in a microfluidic droplet format was
realised. A standard T-junction configuration was employed to
generate aqueous droplets in the oil carrier fluid. The two
aqueous phases, PEG and DEX solutions, were delivered into
the microfluidic device through 2 separate aqueous inlets
(Fig. 1a). Upstream of the T-junction, the two solutions form
a laminar flow arrangement with a clean and stable interface
(Fig. 1b). At the T-junction, droplets containing both phases
were formed in a highly reproducible fashion. Moreover, a defi-
nite separation between the two phases was observed at the
second serpentine channel (as shown in the inset of Fig. 1b).
Since the DEX flow rate is much smaller than the PEG flow rate
the smaller droplet is composed of DEX, while the PEG phase
forms the outer droplet that encapsulates the DEX phase. The
phase configuration can also be predicted on the basis of the
interfacial tension.33,34 With interfacial tension g, for phases 1
and 3 suspended in a phase 2, phase 1 is completely engulfed by
phase 3, when g12 > g23. So we may assume that for this ATPS,
gDEX-oil is larger than goil-PEG. A cartoon of this arrangement is
shown in Fig. 1e.
It was found that the entire droplet must be smaller than the
cross-sectional channel dimension to maintain a stable separa-
tion of the two phases; we obtain spherical droplets with
diameters in the range of 90–95 mm. Conversely, when plugs
form, contact with the channel walls enables mixing within the
droplets, such that the two-phase interface does not form. The
smaller droplet size was achieved by using a restricted T-junction
configuration, i.e. at the T-junction the channel width is
approximately 45 mm, with the channel subsequently dilating to
a width of 100 mm.
As in bulk experiments, the two phases must be mixed to
achieve partitioning of the contained cells. This process can be
expedited by agitating the ATPS after addition of the cells, which
affords close contact between the two phases within a short time
period. Though the distribution of the cells takes place during
agitation, it is only after the two phases separate and form a clean
interface that the distribution can be experimentally determined
and processed. In a segmented-flow microfluidic platform, the
most facile way to ensure complete mixing within each droplet is
by way of chaotic advection. To initiate chaotic advection we
integrated a winding channel section of smaller cross-sectional
width than the droplets. Unfortunately, initial experiments
showed that the increased pressure (due to a decreased channel
volume) destabilises the ATPS, such that a clean separation is
not possible. To overcome this problem and maintain the
upstream channel volume, the channel was divided into two
paths, one wider droplet path and one much narrower oil path.
After entering the winding channel section, droplets were sub-
jected to efficient chaotic mixing and consequently, the two
phases were mixed thoroughly (Fig. 1c). Importantly, the PEG–
DEX interface is re-established at the following second serpen-
tine channel. The PEG and DEX droplet sizes were directly
controlled via variation of the flow rates of the aqueous inlets,
while the total droplet size was determined by the water fraction
(the ratio of the total aqueous flow to the sum of the aqueous and
oil flows).3 Typical oil and (total) aqueous flow rates were 4.0 ml
min1 and 1.5 ml min1, respectively, thus generating a water
fraction of 0.27. The effect of the ratio of the two aqueous phases
on the PEG and DEX droplet sizes was investigated. While the
PEG droplet size only changes minimally, the DEX droplet size
decreases significantly, when the flow rate is varied by 0.4 ml
min1 (Fig. 2). For the cell experiments described herein, the
most suitable flow rates were determined to be oil¼ 4.0 ml min1,
PEG ¼ 1.4 ml min1 and DEX ¼ 0.1 ml min1. These conditions
generated droplets large enough to hold cells in either the DEX
or PEG phase, with diameters of approximately (93  5) mm for
the PEG droplet and (41  5) mm for DEX.
Cell sample preparation
Fig. 3a shows a bright field image of Jurkat cells prior to incu-
bation in Ab-NIPAM. Since FITC is bound to the Ab, the effi-
ciency of Ab binding to the Jurkat cell surface can be determined
by comparing fluorescence images before and after incubation.
Fig. 3b illustrates the auto-fluorescence of cells, while the fluo-
rescence of the cell after incubation is shown in Fig. 3d. The
fluorescence intensity is significantly higher after incubation,
indicating successful binding of the Ab-NIPAM conjugate to the
Jurkat cell surface. Moreover, binding of the Ab-NIPAM
conjugate to the cell surface is evident in the associated bright
field image (Fig. 3c), with the cells appearing to be well coated by
the polymer. It should be noted that the cell density after the
Fig. 1 (a) Schematic illustrating device design. (b) Image showing
droplet formation at the T-junction, with an inset showing an ATPS
droplet further downstream. (c) The mixing region in the channel
network. Droplets follow the winding channel path, which induces
mixing through chaotic advection. Oil flows through the narrow channel
path. (d) Image showing a complete device (channels are filled with blue
dye for visualisation). (e) A sketch to illustrate the ATPS in a microfluidic
droplet, with the PEG phase encapsulating the smaller DEX droplet.


































centrifugation is considerably lower than the initial density. This
is a result of cells being lost both during the centrifugation step
and also during the transfer from the filter units to the syringe.
To acquire a reasonable cell density in the syringe, an initial cell
density of 3  106 cells ml1 was used for all experiments. The
cells are viable post Ab-NIPAM treatment. Importantly, it
should be noted that FITC was used in the current experiments
as a way of monitoring the success of the binding of the Ab-
NIPAM conjugate to the cell surface and analogous experiments
can be carried out on populations without the fluorescence tag.
Partitioning of cells
The DEX sample containing the Jurkat-Ab-NIPAM conjugates
was delivered into one aqueous inlet and the PEG solution
introduced into the other aqueous inlet. Accordingly, cells enter
the aqueous two phase microdroplet system within the DEX
solution (Fig. 4a) and remain within the DEX droplet even after
the interface between the two aqueous phases is established
(Fig. 4b). It should also be noted that due to the high viscosity of
DEX, a much smaller daughter droplet is also formed during the
generation process. This droplet does not interfere with any
downstream droplet manipulations. During the winding channel
section, the two phases are thoroughly mixed, such that cells are
free to experience both phases. At this point, the cells are close to
both phases and once past the mixing section, the cells can be
partitioned to the outer PEG phase, as seen in Fig. 4c. The mixing
time in the winding channel is estimated to be 200 ms and upon
exiting the winding channel section the phases separate within 650
ms. To assess the portioning process, the location of cells before
and after mixing was evaluated. Using the centre of the DEX
droplet as a reference point, the radial distance of the cell location
from this position was determined (Fig. 5). Droplet videos were
analysed using commercially available software (Image
J, National Institutes of Health), and the distance from the DEX
centre to the cell (for 150 droplets) for each condition were
extracted. The error on the cell location measurement was esti-
mated to be 5 mm. Analysing images limits location measurements
Fig. 2 The dependence of PEG and DEX droplet size on flow rate ratios.
The oil flow rate is held constant at 4 ml min1. The aqueous flow rate
ratio is varied, whilst maintaining a total aqueous flow rate of 1.5 ml
min1.
Fig. 3 (a) Jurkat cells on a cover slip after harvesting from a cell culture,
and (b) auto-fluorescence of cells when excited with 488 nm radiation.
Note that the high intensity at the centre of the image is due to the
excitation laser scattering. (c) Bright field image of Jurkat cells in DEX
after incubation in the Ab-NIPAM conjugate and (d) fluorescence from
harvested cells when excited with 488 nm radiation. Note that images (c)
and (d) do not correlate directly. All cells labelled with Ab-NIPAM
conjugates fluoresce.
Fig. 4 Cells with Ab-NIPAM conjugate in DEX at a microfluidic
T-junction (a) and in a DEX droplet prior to mixing (b). Note that
although small daughter droplets are formed, they do not merge with the
larger ATPS droplets. After mixing, cells partition to the outer PEG
phase (c). (Cells are indicated by arrows).


































to the lateral radial distance of the cells. To determine which
phase the cells reside in, observations were made from the point of
reforming of the ATPS after the winding channel section to the
exit of the device. Cells residing within the DEX droplet move in
and out of focus but do not cross the PEG–DEX boundary. Cells
within the PEG phase also move in and out of focus, but when
cells are laterally adjacent to the DEX droplet, they are clearly
identifiable to be in the PEG phase and the radial distance can be
measured. If cells in the PEG phase are below or above the DEX
droplet, they are observed to move laterally adjacent to the DEX
further downstream. Thus, tracing the cell location allows for
definite identification of the phase in which the cells reside. Before
incubation in Ab-NIPAM, the cells clearly remain in the DEX
droplet, with 98% being located within the DEX droplet. Once
cells have bound to Ab-NIPAM conjugate, they partition to the
PEG phase, such that approximately 93% of cells are found in the
outer PEG droplet. Additionally, it was found that cells
predominantly localise well away from the PEG–DEX boundary.
Various factors will affect the exact location of the cells within the
PEG phase. These include the initial position of the cell when
droplets are formed at the T-junction, the input flow rates utilised,
the stability of the system and the position of the cells as droplets
enter the mixing region.
Conclusions
Herein, we have demonstrated that an ATPS can be realised in
a microfluidic droplet format, suggesting significant opportuni-
ties in cell sorting in a high-throughput manner. Indeed, we
believe that this technique is highly applicable to separating
a heterogeneous cell population in high-throughput. The use of
Ab-NIPAM conjugates can be applied to other cell systems,
given that a suitable Ab is chosen, thus giving this method a wide
range of applications. Moreover, the microfluidic system can
easily be modified to separate the aqueous droplets from the oil
phase35 and subsequently separate the two aqueous phases to
extract cells. Accordingly, clean cell samples can be used for
further analysis or manipulations.
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